Hematogenous metastasis: Roles of CD44v and alternative sialofucosylated selectin ligands

Advances in Experimental Medicine and Biology

Volumn 705, Issue , 2011, Pages 601-619

  Konstantopoulos, Konstantinos ^a   Thomas, Susan N ^b  

^a Johns Hopkins University   (United States)

^b NONE

Author keywords

CD44; Colon carcinoma cells; Metastasis; Selectin; Shear flow

Indexed keywords

CD24 ANTIGEN; CD44V ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ISOPROTEIN; LIGAND; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PROTEINASE; SELECTIN; THROMBIN RECEPTOR; CD44 PROTEIN, HUMAN; FUCOSE; HERMES ANTIGEN; PEPTIDE HYDROLASE; SIALIC ACID DERIVATIVE; SMALL INTERFERING RNA;

BINDING SITE; CANCER CELL CULTURE; CARBOHYDRATE ANALYSIS; CELL ADHESION; CELL ASSAY; CELL FREE SYSTEM; CELL SURFACE; COLON CARCINOMA; CONFERENCE PAPER; FUCOSYLATION; HEMATOGENOUS METASTASIS; HUMAN; METASTASIS; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SENSITIVITY ANALYSIS; SIALYLATION; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION; ARTICLE; CARCINOMA; CHEMISTRY; COLON TUMOR; DRUG EFFECT; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PLASMID; PROTEIN BINDING; THROMBOCYTE; TUMOR CELL LINE;

ANTIGENS, CD44; BINDING SITES; BLOOD PLATELETS; CARCINOMA; CELL ADHESION; CELL LINE, TUMOR; COLONIC NEOPLASMS; FUCOSE; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOPLASM METASTASIS; P-SELECTIN; PEPTIDE HYDROLASES; PLASMIDS; PROTEIN BINDING; RNA, SMALL INTERFERING; SIALIC ACIDS; TRANSFECTION;

EID: 80054023220     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-7877-6_32     Document Type: Conference Paper

References (86)

1. Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A (2001) Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 98:3352-3357
2. Borsig L, Wong R, Hynes RO, Varki NM, Varki A (2002) Synergistic effects of L-and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA 99:2193-2198
3. Kim YJ, Borsig L, Varki NM, Varki A (1998) P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 95:9325-9330
4. Kaytes PS, Geng JG (1998) P-selectin mediates adhesion of the human melanoma cell line NKI-4: identification of glycoprotein Ligands. Biochemistry 37:10514-10521
5. Kim YJ, Borsig L, Han HL, Varki NM, Varki A (1999) Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol 155:461-472
6. Li L, Short HJ, Qian KX, Elhammer AP, Geng JG (2001) Characterization of glycoprotein ligands for P-selectin on a human small cell lung cancer cell line NCI-H345. Biochem Biophys Res Commun 288:637-644
7. Varki A (1997) Selectin ligands: will the real ones please stand up? J Clin Invest 100:S31-S35
8. Konstantopoulos K, Neelamegham S, Burns AR, Kansas GS, Snapp KR, Berg E, Hellums JD, Smith CW, Mclntire LV, Simon SI (1998) Venous levels of shear induce neutrophil-platelet adhesion and neutrophil aggregation mediated by P-selectin and b2-integrins. Circulation 98:873-882
9. Lowe JB, Ward PA (1997) Therapeutic inhibition of carbohydrate-protein interactions in vivo. J Clin Invest 99:822-826
10. Kansas GS (1996) Selectins and their ligands: current concepts and controversies. Blood 88:3259-3287
11. McEver RP (2002) Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol 14:581-586
12. Guyer DA, Moore KL, Lynam EB, Schammel CMG, Rogelj S, McEver RP, Sklar LA (1996) P-selectin glycoprotein ligand-1 is a ligand for L-selectin in neutrophil aggregation. Blood 88:2415-2421
13. Hanley WD, Wirtz D, Konstantopoulos K (2004) Distinct kinetic and mechanical properties govern selectin-leukocyte interactions. J Cell Sci 117:2503-2511
14. Sperandio M, Smith ML, Forlow SB, Olson TS, Xia L, McEver RP, Ley K (2003) P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules. J Exp Med 197:1355-1363
15. Walcheck B, Moore KL, McEver RP, Kishimoto TK (1996) Neutrophil- neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation on P-selectin in vitro. J Clin Invest 98:1081-1087
16. Jadhav S, Bochner BS, Konstantopoulos K (2001) Hydrodynamic shear regulates the kinetics and receptor specificity of polymorphonuclear leukocyte -colon carcinoma cell adhesive interactions. J Immunol 167:5986-5993
17. Jadhav S, Konstantopoulos K (2002) Fluid shear-and time-dependent modulation of molecular interactions between polymorphonuclear leukocytes and colon carcinomas. Am J Physiol Cell Physiol 283:C1133-C1143
18. Mannori G, Crottet P, Cecconi O, Hanasaki K, Aruffo A, Nelson RM, Varki A, Bevilacqua MP (1995) Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins. Cancer Res 55:4425-4431
19. Cotran RS, Gimbrone MA Jr, Bevilacqua MP, Mendrick DL, Pober JS (1986) Induction and detection of a human endothelial activation antigen in vivo. J Exp Med 164:661-666
20. Yao L, Pan J, Setiadi H, Patel KD, McEver RP (1996) Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J Exp Med 184:81-92
21. Lenter M, Levinovitz A, Isenmann S, Vestweber D (1994) Monospecific and common glycoprotein ligands for E-and P-selectin on myeloid cells. J Cell Biol 125:471-481
22. Burdick MM, McCaffery JM, Kim YS, Bochner BS, Konstantopoulos K (2003) Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow. Am J Physiol Cell Physiol 284:C977-C987
23. McCarty OJT, Jadhav S, Burdick MM, Bell WR, Konstantopoulos K (2002) Fluid shear regulates the kinetics and molecular mechanisms of activation-dependent platelet binding to colon carcinoma cells. Biophys J 83:836-848
24. McCarty OJT, Mousa SA, Bray PF, Konstantopoulos K (2000) Immobilized platelets support human colon carcinoma cell tethering, rolling and firm adhesion under dynamic flow conditions. Blood 96:1789-1797
25. Stone JP, Wagner DD (1993) P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest 92:804-813
26. Romo GM, Dong JF, Schade AJ, Gardiner EE, Kansas GS, Li CQ, McIntire LV, Berndt MC, Lopez JA (1999) The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 190:803-814
27. Diacovo TG, Puri KD, Warnock RA, Springer TA, von Andrian UH (1996) Platelet-mediated lymphocyte delivery to high endothelial venules. Science 273:252-255
28. Jadhav S, Eggleton CD, Konstantopoulos K (2007) Mathematical modeling of cell adhesion in shear flow pertinent to inflammation and cancer metastasis. Curr Pharm Des 13:1511-1526
29. Malhotra R, Taylor NR, Bird MI (1996) Anionic phospholipids bind to L-selectin (but not E-selectin) at a site distinct from the carbohydrate-binding site. Biochem J 314:297-303
30. Moore KL, Stults NL, Diaz S, Smith DF, Cummings RD, Varki A, McEver RP (1992) Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol 118:445-456
31. Sako D, Chang XJ, Barone KM, Vachino G, White HM, Shaw G, Veldman GM, Bean KM, Ahern TJ, Furie B et al (1993) Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 75:1179-1186
32. McEver RP, Cummings RD (1997) Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 100:S97-S103
33. Frenette PS, Denis CV, Weiss L, Jurk K, Subbarao S, Kehrel B, Hartwig JH, Vestweber D, Wagner DD (2000) P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 191:1413-1422
34. Leppanen A, Mehta P, Ouyang YB, Ju T, Helin J, Moore KL, van Die I, Canfield WM, McEver RP, Cummings RD (1999) A novel glycosulfopeptide binds to P-selectin and inhibits leukocyte adhesion to P-selectin. J Biol Chem 274:24838-24848
35. Patel KD, Moore KL, Nollert MU, McEver RP (1995) Neutrophils use both shared and distinct mechanisms to adhere to selectins under static and flow conditions. J Clin Invest 96:1887-1896
36. Afshar-Kharghan V, Diz-Kucukkaya R, Ludwig EH, Marian AJ, Lopez JA (2001) Human polymorphism of P-selectin glycoprotein ligand 1 attributable to variable numbers of tandem decameric repeats in the mucin like region. Blood 97:3306-3307
37. Aigner S, Ramos CL, Hafezi-Moghadam A, Lawrence MB, Friederichs J, Altevogt P, Ley K (1998) CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J 12:1241-1251
38. Aigner S, Sthoeger ZM, Fogel M, Weber E, Zarn J, Ruppert M, Zeller Y, Vestweber D, Stahel R, Sammar M, Altevogt P (1997) CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 89:3385-3395
39. Friederichs J, Zeller Y, Hafezi-Moghadam A, Grone HJ, Ley K, Altevogt P (2000) The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. Cancer Res 60:6714-6722
40. Koenig A, Norgard-Sumnicht K, Linhardt R, Varki A (1998) Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest 101:877-889
41. Needham LK, Schnaar RL (1993) The HNK-1 reactive sulfoglucuronyl glycolipids are ligands for L-selectin and P-selectin but not E-selectin. Proc Natl Acad Sci USA 90:1359-1363
42. Gasic GJ, Gasic TB, Stewart CC (1968) Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci USA 61:46-52
43. Martin TA, Harrison G, Mansel RE, Jiang WG (2003) The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol 46:165-186
44. Ponta H, Wainwright D, Herrlich P (1998) The CD44 protein family. Int J Biochem Cell Biol 30:299-305
45. Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4:33-45
46. Borland G, Ross JA, Guy K (1998) Forms and functions of CD44. Immunology 93:139-148
47. Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A (1993) Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 122:257-264
48. Culty M, Miyake K, Kincade PW, Sikorski E, Butcher EC, Underhill C (1990) The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 111:2765-2774
49. Jalkanen S, Jalkanen M (1992) Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116:817-825
50. Harada N, Mizoi T, Kinouchi M, Hoshi K, Ishii S, Shiiba K, Sasaki I, Matsuno S (2001) Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells. Int J Cancer 91:67-75
51. Labarriere N, Piau JP, Otry C, Denis M, Lustenberger P, Meflah K, Le Pendu J (1994) H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells. Cancer Res 54:6275-6281
52. Reeder JA, Gotley DC, Walsh MD, Fawcett J, Antalis TM (1998) Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Cancer Res 58:3719-3726
53. Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, van den Berg FM, Ponta H, Herrlich P, Pals ST (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53:4754-4756
54. Kim H, Yang XL, Rosada C, Hamilton SR, August JT (1994) CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Arch Biochem Biophys 310:504-507
55. Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H, Pals ST (1999) Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 154:515-523
56. Kim HR, Wheeler MA, Wilson CM, Iida J, Eng D, Simpson MA, McCarthy JB, Bullard KM (2004) Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Res 64:4569-4576
57. Ropponen K, Tammi M, Parkkinen J, Eskelinen M, Tammi R, Lipponen P, Agren U, Alhava E, Kosma VM (1998) Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 58:342-347
58. Gao AC, Lou W, Dong JT, Isaacs JT (1997) CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res 57:846-849
59. Shtivelman E, Bishop JM (1991) Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol 11:5446-5453
60. Burdick MM, McCarty OJT, Jadhav S, Konstantopoulos K (2001) Cell-cell interactions in inflammation and cancer metastasis. IEEE Eng Med Biol Mag 20:86-91
61. Krause T, Turner GA (1998) Are selectins involved in metastasis? Clin Exp Metastasis 17:183-192
62. Sass PM (1998) The involvement of selectins in cell adhesion, tumor progression, and metastasis. Cancer Invest 16:322-328
63. Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N (2004) Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 95:377-384
64. Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Kabuto T, Iwanaga T, Matsushita Y, Irimura T (1993) Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohis-tochemical study. Cancer Res 53:3632-3637
65. Nakayama T, Watanabe M, Katsumata T, Teramoto T, Kitajima M (1995) Expression of sialyl Lewis(a) as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer 75:2051-2056
66. Sato M, Narita T, Kimura N, Zenita K, Hashimoto T, Manabe T, Kannagi R (1997) The association of sialyl Lewis(a) antigen with the metastatic potential of human colon cancer cells. Anticancer Res 17:3505-3511
67. Karpatkin S, Pearlstein E, Ambrogio C, Coller BS (1988) Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest 81:1012-1019
68. Camerer E, Qazi AA, Duong DN, Cornelissen I, Advincula R, Coughlin SR (2004) Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 104:397-401
69. Nieswandt B, Hafner M, Echtenacher B, Mannel DN (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59:1295-1300
70. Burdick MM, Konstantopoulos K (2004) Platelet-induced enhancement of LS174T colon carcinoma and THP-1 monocytoid cell adhesion to vascular endothelium under flow. Am J Physiol Cell Physiol 287:C539-C547
71. Felding-Habermann B, Habermann R, Salvidar E, Ruggeri ZM (1996) Role of b3 integrins in melanoma cell adhesion to activated platelets under flow. J Biol Chem 271:5892-5900
72. Hanley W, McCarty O, Jadhav S, Tseng Y, Wirtz D, Konstantopoulos K (2003) Single molecule characterization of P-selectin/ligand binding. J Biol Chem 278:10556-10561
73. McCarty OJ, Tien N, Bochner BS, Konstantopoulos K (2003) Exogenous eosinophil activation converts PSGL-1-dependent binding to CD18-dependent stable adhesion to platelets in shear flow. Am J Physiol Cell Physiol 284:C1223-C1234
74. Ahn KC, Jun AJ, Pawar P, Jadhav S, Napier S, McCarty OJ, Konstantopoulos K (2005) Preferential binding of platelets to monocytes over neutrophils under flow. Biochem Biophys Res Commun 329:345-355
75. Goetz DJ, Ding H, Atkinson WJ, Vachino G, Camphausen RT, Cumming DA, Luscinskas FW (1996) A human colon carcinoma cell line exhibits adhesive interactions with P-selectin under fluid flow via a PSGL-1-independent mechanism. Am J Pathol 149:1661-1673
76. Honn KV, Tang DG, Crissman JD (1992) Platelets and cancer metastasis. Cancer Metastasis Rev 11:325-351
77. Oleksowicz L, Mrowiec Z, Schwartz E, Khorshidi M, Dutcher JP, Puszkin E (1995) Characterization of tumor-induced platelet aggregation: the role of immunorelated GPIb and GPIIb/IIIa expression by MCF-7 breast cancer cells. Thromb Res 79:261-274
78. Abe A, Radin N, Shayman J, Wotring L, Zipkin R, Sivakumar R, Ruggieri J, Carson K, Ganem B (1995) Structural and stereochemical studies of potent inhibitors of glucosylcer-amide synthase and tumor cell growth. J Lipid Res 36:611-621
79. Kojima N, Handa K, Newman W, Hakomori S (1992) Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blocking O-glycosylation of these cells. Biochem Biophys Res Commun 182:1288-1295
80. Kuan SF, Byrd JC, Basbaum C, Kim YS (1989) Inhibition of mucin glycosylation by aryl-N-acetyl-alpha-galactosaminides in human colon cancer cells. J Biol Chem 264:19271-19277
81. Hanley WD, Burdick MM, Konstantopoulos K, Sackstein R (2005) CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity. Cancer Res 65:5812-5817
82. Hanley WD, Napier SL, Burdick MM, Schnaar RL, Sackstein R, Konstantopoulos K (2006) Variant isoforms of CD44 are P-and L-selectin ligands on colon carcinoma cells. FASEB J 20:337-339
83. Fuhlbrigge RC, King SL, Dimitroff C, Kupper TS, Sackstein R (2002) Direct real-time observation of E-and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on western blots. J Immunol 168:5645-5651
84. Napier SL, Healy ZR, Schnaar RL, Konstantopoulos K (2007) Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44V and alternative sialofucosylated selectin ligands. J Biol Chem 282:3433-3441
85. Dimitroff CJ, Lee JY, Fuhlbrigge RC, Sackstein R (2000) A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proc Natl Acad Sci USA 97:13841-13846
86. Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, Sackstein R (2001) CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol 153:1277-1286